社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
KALA BIO(KALA)
盘前
0.2839
-0.01
-4.35%
04:41 EDT
0.2968
-0.0681
-18.66%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
KALA BIO
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.kalarx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
KALA BIO, Inc.于2009年7月7日根据德拉华州的法律，以Hanes Newco，Inc.的名义成立。该公司于2009年12月11日更名为Kala Pharmaceuticals，Inc.。该公司是一家生物制药公司，专注于使用其专有的基于纳米颗粒的胶质渗透颗粒或MPP技术开发和商业化治疗，其初步重点是治疗眼部疾病。它们的MPP是选择性尺寸的纳米颗粒并具有专有涂层。该公司认为，这两个关键特征使得药物颗粒在粘膜表面上的均匀分布，并且通过增加药物颗粒通过粘液的流动性并且防止药物颗粒被粘液捕获和消除而显著地增加了对靶组织的药物递送。该公司已经应用MPP技术来创建百宝普尔乙酸钙的纳米悬浮液，或LE，一种为眼部应用设计的皮质类固醇，从而在3期临床开发中获得两个候选药物，KPI-121 1.0％用于治疗眼外科手术后的炎症和疼痛 和KPI-121 0.25％用于临时缓解干眼症的体征和症状。
03-04
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-20
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-06
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-02
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-23
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-08
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-06
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-02
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-29
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-26
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-19
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
分时
5日
日
周
月
数据加载中...
最高
0.3380
今开
0.3345
量比
0.37
最低
0.2877
昨收
0.3649
换手率
2.45%
热议股票
{"pagemeta":{"title":"KALA BIO(KALA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供KALA BIO(KALA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"KALA BIO,KALA,KALA BIO股票,KALA BIO股票老虎,KALA BIO股票老虎国际,KALA BIO行情,KALA BIO股票行情,KALA BIO股价,KALA BIO股市,KALA BIO股票价格,KALA BIO股票交易,KALA BIO股票购买,KALA BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"KALA BIO(KALA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供KALA BIO(KALA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"KALA","data":{"stockData":{"symbol":"KALA","market":"US","secType":"STK","nameCN":"KALA BIO","latestPrice":0.2968,"timestamp":1773345600000,"preClose":0.3649,"halted":0,"volume":22293988,"hourTrading":{"tag":"盘前","latestPrice":0.2839,"preClose":0.2968,"latestTime":"04:41 EDT","volume":663,"amount":190.79368464,"timestamp":1773391289797,"change":-0.0129,"changeRate":-0.043464,"amplitude":0.013814},"delay":0,"changeRate":-0.18662647300630308,"floatShares":911000000,"shares":911000000,"eps":-5.825375,"marketStatus":"盘前交易","change":-0.0681,"latestTime":"03-13 04:45:44 EDT","open":0.3345,"high":0.33795,"low":0.2877,"amount":6925030.56214124,"amplitude":0.137709,"askPrice":0.304,"askSize":151,"bidPrice":0.28,"bidSize":5175,"shortable":0,"etf":0,"ttmEps":-5.825375,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773408600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1500523200000,"exchange":"NASDAQ","adjPreClose":0.2968,"preHourTrading":{"tag":"盘前","latestPrice":0.2839,"preClose":0.2968,"latestTime":"04:41 EDT","volume":663,"amount":190.79368464,"timestamp":1773391289797,"change":-0.0129,"changeRate":-0.043464,"amplitude":0.013814},"postHourTrading":{"tag":"盘后","latestPrice":0.2937,"preClose":0.2968,"latestTime":"19:59 EDT","volume":895199,"amount":267080.41205,"timestamp":1773359981462,"change":-0.0031,"changeRate":-0.010445,"amplitude":0.054582},"volumeRatio":0.37357369255715006,"impliedVol":0.9132,"impliedVolPercentile":0},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20797961","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626001911-KALA","pdf_url":"","pub_time":1772600400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/0001829126-26-001911-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/kalabio_ex10-1.htm","primary":true,"translateUrl":"","linkName":"kalabio_ex10-1.htm","type":"EX-10.1","id":"NTFILE4v5F91yeqpdmLnvq","market":"us","size":285277},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/kalabio_8k.htm","primary":false,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILECCsjjnpQGNcz95TX","market":"us","size":40941},{"description":"EXHIBIT 99.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/kalabio_ex99-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex99-1.htm","type":"EX-99.1","id":"NTFILEN15GWpiBauNxGcKP","market":"us","size":70134}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-04 13:00","pubTimestamp":1772600400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；第7.01项：法规FD披露","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20754066","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626001534-KALA","pdf_url":"","pub_time":1771563600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001534/0001829126-26-001534-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626001534/kalabio_8k.htm","primary":true,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILE4bPa6sPnsQec4Dbm","market":"us","size":32142}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-20 13:00","pubTimestamp":1771563600,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20706594","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626000995-KALA","pdf_url":"","pub_time":1770325529000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/0001829126-26-000995-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000995/kalabio_8k.htm","primary":true,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILE2XCNXPVbbQFfp5De","market":"us","size":24813}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-06 05:05","pubTimestamp":1770325529,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20687228","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626000837-KALA","pdf_url":"","pub_time":1770008400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/0001829126-26-000837-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/kalabio_ex3-1.htm","primary":true,"translateUrl":"","linkName":"kalabio_ex3-1.htm","type":"EX-3.1","id":"NTFILE7MJjeA9owBiWjjrR","market":"us","size":77246},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/kalabio_8k.htm","primary":false,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILE3bvGmcaxKnSnNc1g","market":"us","size":69565},{"description":"EXHIBIT 3.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/kalabio_ex3-2.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex3-2.htm","type":"EX-3.2","id":"NTFILE4wMF85RLxVnqkAyT","market":"us","size":15291},{"description":"EXHIBIT 10.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/kalabio_ex10-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-1.htm","type":"EX-10.1","id":"NTFILE6VB6V5nAq3Mgddv6","market":"us","size":190591}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-02 13:00","pubTimestamp":1770008400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；第5.01项：注册人控制权的变更；第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；第5.03项：公司章程或章程的修订；财政年度的变化；项目5.07：将事项提交证券持有人表决；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20659724","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626000502-KALA","pdf_url":"","pub_time":1769144400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000502/0001829126-26-000502-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000502/kalabio_8k.htm","primary":true,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILECVMcvic71VARrkTb","market":"us","size":26838}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-23 13:00","pubTimestamp":1769144400,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20616527","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626000110-KALA","pdf_url":"","pub_time":1767848400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/0001829126-26-000110-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 1.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/kalabio_ex1-1.htm","primary":true,"translateUrl":"","linkName":"kalabio_ex1-1.htm","type":"EX-1.1","id":"NTFILECjZYNRCbHP4vKPnG","market":"us","size":245344},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/kalabio_8k.htm","primary":false,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILECExpE4HpeJQtqX3v","market":"us","size":33845},{"description":"EXHIBIT 5.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/kalabio_ex5-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex5-1.htm","type":"EX-5.1","id":"NTFILE3j9k8VfDUWtAi2t9","market":"us","size":16104},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEEsTUuqJ6V3DHeqXM","market":"us","size":4382},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEGvKhyGMSRxTKjHD2","market":"us","size":1953}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-08 13:00","pubTimestamp":1767848400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20606841","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626000055-KALA","pdf_url":"","pub_time":1767675600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/0001829126-26-000055-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/kalabio_ex10-1.htm","primary":true,"translateUrl":"","linkName":"kalabio_ex10-1.htm","type":"EX-10.1","id":"NTFILEGgsuoSXQ3eXviJwh","market":"us","size":26759},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/kalabio_8k.htm","primary":false,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILEDqckTjWnwkLD62S4","market":"us","size":34207},{"description":"EXHIBIT 10.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/kalabio_ex10-2.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-2.htm","type":"EX-10.2","id":"NTFILE5STg8RY8KbvvnTco","market":"us","size":42294},{"description":"EXHIBIT 10.3","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/kalabio_ex10-3.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-3.htm","type":"EX-10.3","id":"NTFILEHonHauYvFY1QiCkm","market":"us","size":25672},{"description":"EXHIBIT 10.4","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/kalabio_ex10-4.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-4.htm","type":"EX-10.4","id":"NTFILEBDLJxN6nbXkkuKQ2","market":"us","size":19306},{"description":"EXHIBIT 99.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000055/kalabio_ex99-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex99-1.htm","type":"EX-99.1","id":"NTFILEBCEDuTs7qbriA8dJ","market":"us","size":5272}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-06 13:00","pubTimestamp":1767675600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20594691","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626000023-KALA","pdf_url":"","pub_time":1767330000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000023/0001829126-26-000023-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000023/kalabio_8k.htm","primary":true,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILEDrEwbwNWkxUQeDgn","market":"us","size":24542}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-02 13:00","pubTimestamp":1767330000,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events","summary_zh":"项目8.01：其他事项","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20579508","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912625010330-KALA","pdf_url":"","pub_time":1766984400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625010330/0001829126-25-010330-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625010330/kalabio_8k.htm","primary":true,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILEB1CS2fanLEypn3WA","market":"us","size":27930}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-29 13:00","pubTimestamp":1766984400,"title_zh":"Form 8-K - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第4.01项：注册人注册会计师的变更；第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20539010","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912625010045-KALA","pdf_url":"","pub_time":1765861200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625010045/0001829126-25-010045-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 16.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625010045/kalabio_ex16-1.htm","primary":true,"translateUrl":"","linkName":"kalabio_ex16-1.htm","type":"EX-16.1","id":"NTFILE5QwiwbrZFubsoFjJ","market":"us","size":2834},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625010045/kalabio_8k.htm","primary":false,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILEBAA5PscD3iGDL2Fi","market":"us","size":28114}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-16 13:00","pubTimestamp":1765861200,"title_zh":"Form 8-K - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第4.01项：注册人注册会计师的变更；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20538626","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912625010037-KALA","pdf_url":"","pub_time":1765861200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625010037/0001829126-25-010037-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625010037/kalabio_8k.htm","primary":true,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILE8uZXEhHM9hafW8M2","market":"us","size":39577}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-16 13:00","pubTimestamp":1765861200,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20497318","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912625009747-KALA","pdf_url":"","pub_time":1764910800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/0001829126-25-009747-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 4.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/kalabio_ex4-1.htm","primary":true,"translateUrl":"","linkName":"kalabio_ex4-1.htm","type":"EX-4.1","id":"NTFILEDvb817iTPmrPuAtj","market":"us","size":89396},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/kalabio_8k.htm","primary":false,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILEBUvpSvxY4tZKJwkq","market":"us","size":35681},{"description":"EXHIBIT 5.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/kalabio_ex5-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex5-1.htm","type":"EX-5.1","id":"NTFILE4AKHzssauR1zKSW1","market":"us","size":19652},{"description":"EXHIBIT 10.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/kalabio_ex10-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-1.htm","type":"EX-10.1","id":"NTFILEBryXi9UbjNxaZXj3","market":"us","size":219606},{"description":"EXHIBIT 99.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/kalabio_ex99-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex99-1.htm","type":"EX-99.1","id":"NTFILEFDsLJXyRVN358jQd","market":"us","size":10829},{"description":"EXHIBIT 99.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/kalabio_ex99-2.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex99-2.htm","type":"EX-99.2","id":"NTFILECTD3wcNias9pPY3t","market":"us","size":9038},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE5swCTucZLb9tR42o","market":"us","size":4398},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE9VDkUGeVVRtu6imo","market":"us","size":1948}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-05 13:00","pubTimestamp":1764910800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20451776","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912625009432-KALA","pdf_url":"","pub_time":1764105331000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/0001829126-25-009432-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 1.02: Termination of a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/kalabio_ex3-1.htm","primary":true,"translateUrl":"","linkName":"kalabio_ex3-1.htm","type":"EX-3.1","id":"NTFILEGtmXhYhwG1YMCUuQ","market":"us","size":76709},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/kalabio_8k.htm","primary":false,"translateUrl":"","linkName":"kalabio_8k.htm","type":"8-K","id":"NTFILE3tY74exUhyTqDzmC","market":"us","size":80929},{"description":"EXHIBIT 4.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/kalabio_ex4-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex4-1.htm","type":"EX-4.1","id":"NTFILEHpEXP1j9jBTALYu8","market":"us","size":3592},{"description":"EXHIBIT 10.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/kalabio_ex10-1.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-1.htm","type":"EX-10.1","id":"NTFILE9pMHtav1aTDPjEay","market":"us","size":268437},{"description":"EXHIBIT 10.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/kalabio_ex10-2.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-2.htm","type":"EX-10.2","id":"NTFILE8kZvZajX6EFhSCoy","market":"us","size":53929},{"description":"EXHIBIT 10.3","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/kalabio_ex10-3.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-3.htm","type":"EX-10.3","id":"NTFILEAATQapT9kdt7ytYF","market":"us","size":62244},{"description":"EXHIBIT 10.4","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/kalabio_ex10-4.htm","primary":false,"translateUrl":"","linkName":"kalabio_ex10-4.htm","type":"EX-10.4","id":"NTFILE9TGVZJSfLztrk1XV","market":"us","size":23739},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/ex4-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex4-1_001.jpg","type":"GRAPHIC","id":"NTFILE6gsHbP8hBvHEiF8t","market":"us","size":1234069},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000182912625009432/ex4-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex4-1_002.jpg","type":"GRAPHIC","id":"NTFILE4QnF8HKvgUY6zNiC","market":"us","size":407080}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-26 05:15","pubTimestamp":1764105331,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 1.02: Termination of a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第1.02项：重大最终协议的终止；第2.03项：直接财务义务或注册人资产负债表外安排下的义务的产生；第3.02项：未经登记的股本证券销售；第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；第5.03项：公司章程或章程的修订；财政年度的变化；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20429297","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925113927-KALA","pdf_url":"","pub_time":1763528400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"KALA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925113927/0001104659-25-113927-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925113927/kala-20250930x10q.htm","primary":true,"translateUrl":"","linkName":"kala-20250930x10q.htm","type":"10-Q","id":"NTFILE37MnaQky595D8gEx","market":"us","size":2249237},{"description":"EX-10.2","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925113927/kala-20250930xex10d2.htm","primary":false,"translateUrl":"","linkName":"kala-20250930xex10d2.htm","type":"EX-10.2","id":"NTFILEAosE3qh9Sk6v7MUn","market":"us","size":151249},{"description":"EX-31.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925113927/kala-20250930xex31d1.htm","primary":false,"translateUrl":"","linkName":"kala-20250930xex31d1.htm","type":"EX-31.1","id":"NTFILE3u1A52yrpMXtqnzU","market":"us","size":14890},{"description":"EX-31.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925113927/kala-20250930xex31d2.htm","primary":false,"translateUrl":"","linkName":"kala-20250930xex31d2.htm","type":"EX-31.2","id":"NTFILE5GfJx4KrpZKHBDv7","market":"us","size":15080},{"description":"EX-32.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925113927/kala-20250930xex32d1.htm","primary":false,"translateUrl":"","linkName":"kala-20250930xex32d1.htm","type":"EX-32.1","id":"NTFILE5V1BKKmcwBU9b3HU","market":"us","size":6688},{"description":"EX-32.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925113927/kala-20250930xex32d2.htm","primary":false,"translateUrl":"","linkName":"kala-20250930xex32d2.htm","type":"EX-32.2","id":"NTFILE48bUsFf4gjBYReK7","market":"us","size":6737}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-19 13:00","pubTimestamp":1763528400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20401927","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925110316-KALA","pdf_url":"","pub_time":1762981292000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"KALA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1479419/0001104659-25-110316-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925110316/kala-20251110x8k.htm","primary":true,"translateUrl":"","linkName":"kala-20251110x8k.htm","type":"8-K","id":"NTFILEDvGCNYDX1rL5wo2o","market":"us","size":29642}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-13 05:01","pubTimestamp":1762981292,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.kalarx.com","stockEarnings":[{"period":"1week","weight":0.0793},{"period":"1month","weight":-0.3059},{"period":"3month","weight":-0.5604},{"period":"6month","weight":-0.9841},{"period":"1year","weight":-0.9573},{"period":"ytd","weight":-0.4661}],"compareEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0377},{"period":"3month","weight":-0.023},{"period":"6month","weight":0.0132},{"period":"1year","weight":0.1918},{"period":"ytd","weight":-0.0233}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"KALA BIO, Inc.于2009年7月7日根据德拉华州的法律，以Hanes Newco，Inc.的名义成立。该公司于2009年12月11日更名为Kala Pharmaceuticals，Inc.。该公司是一家生物制药公司，专注于使用其专有的基于纳米颗粒的胶质渗透颗粒或MPP技术开发和商业化治疗，其初步重点是治疗眼部疾病。它们的MPP是选择性尺寸的纳米颗粒并具有专有涂层。该公司认为，这两个关键特征使得药物颗粒在粘膜表面上的均匀分布，并且通过增加药物颗粒通过粘液的流动性并且防止药物颗粒被粘液捕获和消除而显著地增加了对靶组织的药物递送。该公司已经应用MPP技术来创建百宝普尔乙酸钙的纳米悬浮液，或LE，一种为眼部应用设计的皮质类固醇，从而在3期临床开发中获得两个候选药物，KPI-121 1.0％用于治疗眼外科手术后的炎症和疼痛 和KPI-121 0.25％用于临时缓解干眼症的体征和症状。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.01363},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.092103},{"month":3,"riseRate":0.555556,"avgChangeRate":0.217018},{"month":4,"riseRate":0.375,"avgChangeRate":-0.095725},{"month":5,"riseRate":0.25,"avgChangeRate":-0.117576},{"month":6,"riseRate":0.5,"avgChangeRate":0.007868},{"month":7,"riseRate":0.375,"avgChangeRate":-0.025178},{"month":8,"riseRate":0.444444,"avgChangeRate":0.043537},{"month":9,"riseRate":0,"avgChangeRate":-0.257871},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.21893},{"month":11,"riseRate":0.555556,"avgChangeRate":0.039437},{"month":12,"riseRate":0.333333,"avgChangeRate":0.569832}],"exchange":"NASDAQ","name":"KALA BIO","nameEN":"KALA BIO"},"aProfile":null}}}